Jamie H. Macdonald
Research Subjects
Jamie H. Macdonald has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Andrew B. Lemmey
School of Sport, Health and Exercise Sciences, University of Wales‐Bangor
2 shared publicationsMahdi Jibani
Department of Nephrology, Gwynedd District General Hospital, Penrhosgarnedd, Bangor, Gwynedd
2 shared publicationsMysore K. Phanish
Department of Nephrology, Gwynedd District General Hospital, Penrhosgarnedd, Bangor, Gwynedd
2 shared publicationsJeff Holly
Division of Surgery, University of Bristol, Bristol Royal Infirmary, Bristol, UK
1 shared publicationJeffrey M.P. Holly
1 shared publicationLionel L.O. Bloodworth
1 shared publication
Latest Publications
- 23 February 2005
- Published by Wiley in Clinical Physiology and Functional Imaging
- Vol. 25 (2) , 113-118
Intradialytic exercise as anabolic therapy in haemodialysis patients – a pilot study
Summary: Haemodialysis (HD) patients are characterized by muscle wasting and consequently decreased physical functioning and poor outcome. This pilot study investigated if a novel intradialytic exercise programme could increase lean mass via up‐regulation of the insulin‐like growth factor (IGF) system. Nine HD patients were assessed before (w‐12) and after a 3‐month control phase (w0), after a three‐month intradialytic interval training programme using high intensity cycle exercise (w12), and after a withdrawal of treatment phase (w24). Body composition was determined by dual energy X‐ray absorptiometry (DEXA) and bioelectrical impedance spectroscopy (BIS); physical functioning by knee extensor strength (KES) and 30‐s sit stand test (SST); and IGF‐I and IGFBP‐3 in serum and muscle by radioimmunoassay. Despite significant increases in training load (+274%, PPPP<0·05) following the intervention phase, lean masses by DEXA, intra cellular water by BIS (a surrogate measure of body cell mass) and serum and muscle IGFs remained unchanged following training. Although this novel exercise programme, utilizing high intensity interval training, was safe, clinically feasible and beneficial in terms of physical functioning, the 12 weeks of intradialytic cycle exercise failed to reverse the muscle atrophy characteristic of this population. Future studies, using primary outcome measures similar to those employed in the present study, should investigate other anabolic interventions to determine potential treatments for the muscle wasting associated with end stage renal disease.
- 23 February 2005
- Published by Wiley in Clinical Physiology and Functional Imaging
- Vol. 25 (2) , 113-118
Intradialytic exercise as anabolic therapy in haemodialysis patients – a pilot study
Summary: Haemodialysis (HD) patients are characterized by muscle wasting and consequently decreased physical functioning and poor outcome. This pilot study investigated if a novel intradialytic exercise programme could increase lean mass via up‐regulation of the insulin‐like growth factor (IGF) system. Nine HD patients were assessed before (w‐12) and after a 3‐month control phase (w0), after a three‐month intradialytic interval training programme using high intensity cycle exercise (w12), and after a withdrawal of treatment phase (w24). Body composition was determined by dual energy X‐ray absorptiometry (DEXA) and bioelectrical impedance spectroscopy (BIS); physical functioning by knee extensor strength (KES) and 30‐s sit stand test (SST); and IGF‐I and IGFBP‐3 in serum and muscle by radioimmunoassay. Despite significant increases in training load (+274%, PPPP<0·05) following the intervention phase, lean masses by DEXA, intra cellular water by BIS (a surrogate measure of body cell mass) and serum and muscle IGFs remained unchanged following training. Although this novel exercise programme, utilizing high intensity interval training, was safe, clinically feasible and beneficial in terms of physical functioning, the 12 weeks of intradialytic cycle exercise failed to reverse the muscle atrophy characteristic of this population. Future studies, using primary outcome measures similar to those employed in the present study, should investigate other anabolic interventions to determine potential treatments for the muscle wasting associated with end stage renal disease.
- 1 October 2004
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 14 (4) , 248-252
Muscle insulin-like growth factor status, body composition, and functional capacity in hemodialysis patients
- 1 October 2004
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 14 (4) , 248-252
Muscle insulin-like growth factor status, body composition, and functional capacity in hemodialysis patients